Clinical and Functional Significance of p38δ (MAPK13) in Lung Cancer
Cancer Genomics - Proteomics · 2026-07 · 23 (4) · 664-685
DOI: 10.21873/cgp.20595 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Genomics - Proteomics, online erschienen am 29.06.2026. Verfasst von Mehek Sumar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, U.S.A. Hauptthemen laut MEDLINE: Lung Neoplasms, Mitogen-Activated Protein Kinase 13, Biomarkers, Tumor. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, U.S.A.
- Norton Thoracic Institute, St. Joseph's Hospital and Medical Center, Phoenix, AZ, U.S.A. narendra.sankpal@commonspirit.org.
Zitieren
APA
Sumar, M., Fleming, T. P., Bremner, R. M., & Sankpal, N. V. (2026). Clinical and Functional Significance of p38δ (MAPK13) in Lung Cancer. Cancer Genomics - Proteomics, 23(4), 664-685. https://doi.org/10.21873/cgp.20595
Vancouver
Sumar M, Fleming TP, Bremner RM, Sankpal NV. Clinical and Functional Significance of p38δ (MAPK13) in Lung Cancer. Cancer Genomics - Proteomics. 2026;23(4):664-685. doi:10.21873/cgp.20595
BibTeX
@article{Sumar2026,
author = {Sumar, Mehek and Fleming, Timothy P and Bremner, Ross M and Sankpal, Narendra V},
title = {Clinical and Functional Significance of p38δ (MAPK13) in Lung Cancer},
journal = {Cancer Genomics - Proteomics},
year = {2026},
volume = {23},
number = {4},
pages = {664--685},
doi = {10.21873/cgp.20595}
}
EUVIMED